Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Industry Leaderboard Gains And Dips Were Still Marked By COVID-19

Dec 04 2023

• By Jessica Merrill and Edwin Elmhirst

Covid trends — • Source: Shutterstock

Related Content

Novartis Slips Into Pfizer's Number One Pharma Slot Amid Leaderboard Shakeup

Dec 06 2021

Pfizer Leads An Unusual Year For The Scrip 100

Dec 13 2022

As Time Ticks, Industry Edges Closer To The Big Patent Cliff

Oct 04 2023

‘It’s A Very Different Story,’ Pfizer CEO Bourla Says Of Cuts To Match COVID Revenue

Oct 16 2023

Sandoz Stands Alone As It Completes Novartis Spinoff

Oct 04 2023

Related Companies

Pfizer Inc.

BioNTech SE

Vaxcyte, Inc

Moderna, Inc.

Gilead Sciences, Inc.

Johnson & Johnson

Merck & Co., Inc.

Novartis AG

Additional Topics

Sales & Earnings Strategy Growth Outlook 2024 Commercial Strategies Infectious Diseases Metabolic Disorders Oncology BioPharmaceutical

More from Outlook 2024

More from In Vivo

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window